Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.

[1]  E. Estey,et al.  The Prognostic Significance of Serum β2 Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients , 2008, Clinical Cancer Research.

[2]  Thomas H Müller,et al.  New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. , 2007, Blood.

[3]  E. Estey,et al.  Levels of soluble HLA-I and β2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy , 2007, Leukemia.

[4]  C. Steidl,et al.  Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS) , 2005, Leukemia.

[5]  J. Bennett.  A comparative review of classification systems in myelodysplastic syndromes (MDS). , 2005, Seminars in oncology.

[6]  E. Estey,et al.  Contribution of beta-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS). , 2003, Blood.

[7]  Terry L. Smith,et al.  Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. , 2002, Blood.

[8]  H. Kantarjian,et al.  Serum β-2 Microglobulin Levels Are a Significant Prognostic Factor in Philadelphia Chromosome-positive Chronic Myelogenous Leukemia , 2000 .

[9]  R. Kyle,et al.  Prognostic factors in multiple myeloma , 1988, Hematological oncology.

[10]  H. Kantarjian,et al.  Chronic lymphocytic leukemia--correlation of response and survival. , 1993, Leukemia & lymphoma.

[11]  E. Estey,et al.  Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. , 1992, The American journal of medicine.

[12]  A. Avilés,et al.  Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma. , 1992, Leukemia & lymphoma.

[13]  S. Tucker,et al.  Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma , 1991 .

[14]  S. Tucker,et al.  A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  L. W. Statius van Eps,et al.  β2-microglobulin: Its significance in the evaluation of renal function , 1987 .

[16]  P. McCue,et al.  Beta-2-microglobulins as a differentiation marker in bladder cancer. , 1986, The Journal of urology.

[17]  H. Whitwell,et al.  Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. , 1984, British Journal of Cancer.